|
AU2016204486A1
|
|
Composition and Methods for Treating Ocular Diseases and Conditions
|
|
AU2015264913A1
|
|
Methods and kits for detecting and diagnosing neurotrauma
|
|
US2016075775A1
|
|
Treatment of traumatic brain injury using antibodies to lysophosphatidic acid
|
|
US2016060328A1
|
|
Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of disease
|
|
AU2015203716A1
|
|
Method and Regents for Detecting Bioactive Lipids
|
|
AU2015201982A1
|
|
Novel Bioactive Lipid Derivatives, Immune-derived Moieties Reactive Thereto, and Methods of Making and Using Same
|
|
AU2014277842A1
|
|
Compositions and Methods for Binding Lysophosphatidic Acid
|
|
AU2014339818A1
|
|
Compositions and methods for binding cysteinyl leukotrienes (cysLTs) for treatment of disease
|
|
AU2014201202A1
|
|
Methods for decreasing immune response and treating immune conditions
|
|
AU2013273727A1
|
|
Compositions and methods for treating ocular diseases and conditions
|
|
US2014186339A1
|
|
Compositions and methods for treating ocular diseases and conditions
|
|
AU2013231110A1
|
|
Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions
|
|
EP2820414A1
|
|
Methods and kits for detecting and diagnosing neurotrauma
|
|
AU2012327166A1
|
|
Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid
|
|
AU2012294413A1
|
|
Stem cell therapy using inhibitors of lysophosphatidic acid
|
|
AU2012202776A1
|
|
Novel Bioactive Lipid Derivatives, Immune-derived Moieties Reactive Thereto, and Methods of Making and Using Same
|
|
AU2012202713A1
|
|
Immune-derived moieties reactive against lysophosphatidic acid
|
|
AU2011279081A1
|
|
Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid
|
|
WO2011156242A2
|
|
Improved anti-lysophospholipid antibody design using antibody structures
|
|
WO2012057877A2
|
|
Combinations of anti-s1p antibodies and sphingolipid pathway inhibitors
|
